Five-Year Lapsed: Review of Laparoscopic Myomectomy versus Open Myomectomy in Putrajaya Hospital
- PMID: 30306035
- PMCID: PMC6172868
- DOI: 10.4103/GMIT.GMIT_38_18
Five-Year Lapsed: Review of Laparoscopic Myomectomy versus Open Myomectomy in Putrajaya Hospital
Abstract
Study objective: This study aimed to investigate the morbidity of laparoscopic myomectomy (LM) versus open myomectomy (OM), including intraoperative blood loss, duration of surgery, hospital stay, and complications and to evaluate the criteria for selection of cases suitable for LM.
Design: This was a retrospective study.
Setting: This study was conducted at tertiary hospital.
Participants: The records of 67 women who underwent LM, 22 women who underwent OM, and 14 women who had laparo-conversion from January 2010 to November 2014 were reviewed.
Measurement and main results: Fibroids up to 10 cm were removed by LM, while most fibroids more than 10 cm were managed through OM. The number and weight of myomas are significantly associated with laparo-conversion, with a rate of 17%. Mean blood loss was significantly reduced in LM group than the OM and laparo-conversion groups. Duration of hospital stay was also significantly less in LM (2 ± 1 days) compared to both OM and laparo-conversion groups (3 ± 1 days). Most women underwent LM (88%) had no postoperative complications compared to OM (50%) and laparo-conversion (57.1%). The number of fibroids removed and duration of surgery was positively correlated with blood loss in the women who underwent myomectomy.
Conclusion: LM is an ideal surgical approach for removal of fibroids which are up to 10 cm diameter and <5 in number, while OM is useful for cases with multiple (5 or more), larger fibroids (>10 cm), and deeply located fibroids. Preoperative evaluation of the size and number of myomas is necessary to avoid laparo-conversion and to reduce intraoperative and postoperative complications.
Keywords: Laparo-conversion; laparoscopy myomectomy; laparotomy; myoma; open myomectomy.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
[Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women].Ceska Gynekol. 2012 Apr;77(2):109-17. Ceska Gynekol. 2012. PMID: 22702067 Clinical Trial. Czech.
-
Analysis of Risk Factors for Intraoperative Conversion of Laparoscopic Myomectomy.J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):352-7. doi: 10.1016/j.jmig.2015.10.017. Epub 2015 Nov 9. J Minim Invasive Gynecol. 2016. PMID: 26546180
-
Perioperative Outcomes of Myomectomy for Extreme Myoma Burden: Comparison of Surgical Approaches.J Minim Invasive Gynecol. 2019 Sep-Oct;26(6):1095-1103. doi: 10.1016/j.jmig.2018.10.022. Epub 2018 Nov 2. J Minim Invasive Gynecol. 2019. PMID: 30391510
-
In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.Cochrane Database Syst Rev. 2020 May 6;5(5):CD013352. doi: 10.1002/14651858.CD013352.pub2. Cochrane Database Syst Rev. 2020. PMID: 32374421 Free PMC article.
-
The effects and costs of laparoscopic versus abdominal myomectomy in patients with uterine fibroids: a systematic review and meta-analysis.BMC Surg. 2020 Mar 20;20(1):55. doi: 10.1186/s12893-020-00703-0. BMC Surg. 2020. PMID: 32192462 Free PMC article.
Cited by
-
Safety and efficacy of lidocaine plus epinephrine on intraoperative bleeding in abdominal myomectomy: A double-blind clinical trial.Health Sci Rep. 2022 Mar 9;5(2):e551. doi: 10.1002/hsr2.551. eCollection 2022 Mar. Health Sci Rep. 2022. PMID: 35284653 Free PMC article.
-
Hydropic leiomyoma-like ovarian tumor: a case report.Fukushima J Med Sci. 2024 Apr 26;70(2):93-98. doi: 10.5387/fms.2023-22. Epub 2024 Mar 15. Fukushima J Med Sci. 2024. PMID: 38494733 Free PMC article.
-
Blood loss from transverse versus longitudinal uterine incision in abdominal myomectomy: a randomized controlled trial.BMC Womens Health. 2020 Dec 28;20(1):259. doi: 10.1186/s12905-020-01113-3. BMC Womens Health. 2020. PMID: 33357218 Free PMC article. Clinical Trial.
-
A case of spontaneous parasitic myoma in a patient without a history of myomectomy treated laparoscopically.Fukushima J Med Sci. 2022 Aug 18;68(2):123-127. doi: 10.5387/fms.2022-08. Epub 2022 Jun 1. Fukushima J Med Sci. 2022. PMID: 35650067 Free PMC article.
-
Analysis of hidden blood loss and its influential factors in myomectomy.J Int Med Res. 2020 May;48(5):300060520920417. doi: 10.1177/0300060520920417. J Int Med Res. 2020. PMID: 32397777 Free PMC article.
References
-
- Lumsden MA. Embolization versus myomectomy versus hysterectomy: Which is best, when? Hum Reprod. 2002;17:253–9. - PubMed
-
- Ryan GL, Syrop CH, Van Voorhis BJ. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol. 2005;48:312–24. - PubMed
-
- Wallach EE, Vlahos NF. Uterine myomas: An overview of development, clinical features, and management. Obstet Gynecol. 2004;104:393–406. - PubMed
-
- Evans P, Brunsell S. Uterine fibroid tumors: Diagnosis and treatment. Am Fam Physician. 2007;75:1503–8. - PubMed
-
- Holzer A, Jirecek ST, Illievich UM, Huber J, Wenzl RJ. Laparoscopic versus open myomectomy: A double-blind study to evaluate postoperative pain. Anesth Analg. 2006;102:1480–4. - PubMed